iLoF: Accelerating access to personalized medicine, from a drop of blood

Portugal

5 min read

Feb 16, 2021

By Emanuela Ferraro

The iLoF founding team (L to R): CTO Joana Paiva, CEO Luís Valente, CSO Paula Sampaio and COO Mehak Mumtaz ©iLoF

Backed by Microsoft’s venture fund M12, Mayfield and Melinda Gates’s Pivotal Ventures, iLoF focuses on painless screening to facilitate disease detection, forecasting and drug development, from Alzheimer’s to Covid-19

Imagine getting your own personalized medical treatment for an illness – say, diabetes or cancer – created using all the biological, medical, behavioral and environmental information known about you. iLoF, a Porto- and Oxford-based precision medicine startup, is working to make that possible, from needing just a single drop of blood from the patient.
The goal: better predictions and preventative measures in early diagnostics, as well as accelerating and optimizing drug and treatment development – through inexpensive and non-invasive patient screening and stratification.
"iLoF w...

The rest of the content is only available if you are logged in.

Edited by Bernice Tang

DATABASE

INSIGHTS

RESEARCH & ANALYSIS

FOLLOW US